— Know what they know.
Not Investment Advice

TMDX NASDAQ

TransMedics Group, Inc.
1W: -6.7% 1M: -15.7% 3M: -10.6% YTD: -43.2% 1Y: -46.6% 3Y: +68.5% 5Y: +157.6%
$69.73
-0.90 (-1.27%)
Pre-Market: $71.36 (+1.63, +2.34%)
Weekly Expected Move ±6.9%
$61 $66 $71 $76 $81
NASDAQ · Healthcare · Medical - Devices · Tech Score Strong Sell · Power 32 · $2.4B mcap · 34M float · 2.63% daily turnover · Short 49% of daily vol
Credit Risk of going bust: higher than 61% of companies Debt: 26.4% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.76 (down 97%), TransMedics Group, Inc. would be worth roughly what it owes.
Total debt $867.7M against a stock market value of $2.42B.
Distance to default 4.16 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $270.6M (short-term plus half of long-term), stock volatility 58.4%; Altman Z 2.41. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$1.1B +32.9% ▲
5Y CAGR: +47.7%
Total Liabilities
$595M +3.4% ▲
5Y CAGR: +65.4%
Shareholders Equity
$473M +107.0% ▲
5Y CAGR: +35.4%
Cash & Investments
$488M +45.1% ▲
5Y CAGR: +31.2%
Total Debt
$470M -9.4% ▼
5Y CAGR: +68.4%
Net Debt
-$19M -110.3% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$26M$201M$395M$337M$488M
Short-Term Investments$67M$0$0$0$0
Cash & ST Investments$92M$201M$395M$337M$488M
Net Receivables$6M$28M$64M$98M$84M
Inventory$15M$21M$44M$47M$49M
Other Current Assets$5M$3M$8M$16M$16M
Total Current Assets$119M$252M$511M$497M$638M
Property, Plant & Equip.$16M$24M$180M$292M$333M
Goodwill & Intangibles$0$0$14M$14M$13M
Long-Term Investments$500K$500K$0$0$0
Other Non-Current Assets$0$0$562K$708K$739K
Total Non-Current Assets$16M$25M$195M$307M$431M
Total Assets$135M$277M$706M$804M$1.1B
— Liabilities —
Accounts Payable$7M$3M$13M$10M$10M
Short-Term Debt$0$0$0$3M$13M
Deferred Revenue$250K$241K$2M$2M$3M
Other Current Liabilities$11M$9M$18M$45M$63M
Total Current Liabilities$23M$24M$55M$60M$89M
Long-Term Debt$35M$59M$506M$509M$456M
Other Non-Current Liab.$0$0$0$0$50M
Total Non-Current Liabilities$44M$66M$514M$516M$506M
Total Liabilities$67M$90M$569M$575M$595M
— Equity —
Common Stock$510M$666M$641M$697M$751M
Retained Earnings-$442M-$479M-$504M-$468M-$278M
Accumulated OCI-$188K-$225K-$199K-$364K$124K
Total Stockholders Equity$68M$187M$137M$229M$473M
Total Liabilities & Equity$135M$277M$706M$804M$1.1B
— Key Metrics —
Total Debt$44M$68M$516M$518M$470M
Net Debt$18M-$134M$121M$182M-$19M
Total Investments$67M$500K$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms